These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8058715)

  • 1. HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy.
    Younes M; Katikaneni PR; Lechago LV; Lechago J
    Mod Pathol; 1994 Apr; 7(3):396-400. PubMed ID: 8058715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correspondence re: Mamoun Younes et al.: HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy. Mod Pathol 7:396, 1994.
    Loy TS
    Mod Pathol; 1995 Apr; 8(3):343-4. PubMed ID: 7617665
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
    Loy TS; Calaluce RD; Keeney GL
    Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.
    Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H
    Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?
    Cheung AN; Chiu PM; Khoo US
    Hum Pathol; 1997 Jan; 28(1):91-4. PubMed ID: 9013838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma.
    Flint A; Lloyd RV
    Arch Pathol Lab Med; 1992 Jan; 116(1):39-42. PubMed ID: 1734831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
    Pires Y; Andrade L; Cuello M; Chuaqui R
    Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
    Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
    Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
    Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
    Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
    DeCostanzo DC; Elias JM; Chumas JC
    Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
    Prat J
    Mod Pathol; 2005 Feb; 18 Suppl 2():S99-111. PubMed ID: 15492758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
    Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
    Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.
    Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM
    Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
    Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
    Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
    Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
    Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.